Physician profile
Sherin E Wesley
NPI 1114091741
$1,449.36
in general payments reported to CMS, 2019-2025
17 companies · $239 in 2025
The $239 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $70.54 · 2021: $87.40 · 2022: $145 · 2023: $274 · 2024: $297 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $400.01 | 2022-2025 | Azstarys |
| Tris Pharma INC | $232.41 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $149.06 | 2020-2025 | Elaprase |
| Cranial Technologies, INC | $126.57 | 2019-2025 | Doc Band |
| Shire North American Group INC | $117.57 | 2019 | |
| Pfizer INC. | $65.84 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $60.84 | 2024 | Qelbree |
| Sobi, INC | $58.00 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $56.80 | 2019-2024 | Gardasil 9, Gardasil |
| Sanofi-Aventis U.S. LLC | $44.12 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $42.42 | 2025 | Neffy |
| Collegium Pharmaceutical, INC. | $19.64 | 2025 | Jornay Pm |
| Kaleo, INC. | $19.53 | 2024 | Auvi-Q |
| Sanofi Pasteur INC. | $15.23 | 2023 | |
| Aytu Biopharma, INC. | $14.95 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $13.70 | 2024 | Cotempla Xr-Odt |
| Mylan Pharmaceuticals INC. | $12.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherin Wesley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.